The Hong Kong government has launched a two-month public consultation on artificial intelligence (AI) and Copyright law. The consultation considers possible improvements to the Copyright Ordinance (Cap. 528) (CO) following...more
A wide-ranging mechanism allowing for easier reciprocal enforcement of judgments in mainland China and Hong Kong will come into force on 29 January 2024. The new enforcement regime should reduce the need to re-litigate...more
As part of a new Asia-Pacific (APAC) Life Sciences and Health Care webinar program designed both for companies with commercial interests in APAC and for companies based in the region, Hogan Lovells is hosting a special...more
As part of a new Asia-Pacific (APAC) Life Sciences and Health Care webinar program designed both for companies with commercial interests in APAC and for companies based in the region, Hogan Lovells is hosting a special...more
Hong Kong Copyright (Amendment) Ordinance was gazetted on 16 December 2022 and introduces important updates to the copyright regime in Hong Kong. The long-awaited update to the Hong Kong copyright regime has crystallised in...more
A wide-ranging mechanism allowing for reciprocal enforcement of judgments in mainland China and Hong Kong has come one stage closer with the gazetting on 4 November 2022 of the Mainland Judgments in Civil and Commercial...more
Following amendments to China's Patent Law in October 2020, China will shortly launch a new patent linkage system for pharmaceutical patents. In order to use the system, holders of existing marketing approvals in China will...more
Companies in the life sciences and health care industry, like most companies, navigated unparalleled challenges in 2020. But unlike other industries, they had to do so while simultaneously facing the biggest challenge of all...more
On 6 July 2020, China's National People’s Congress (NPC) released its latest Draft Patent Law for public comment, proposing, amongst other things, a patent linkage system, patent term extension for pharmaceutical patents,...more
Earlier this year, the Shanghai IP Court (“Court”) handed down an interesting judgment in a patent infringement case between a French car parts manufacturer and three Chinese defendants (two Xiamen, Fujian Province based...more
In a recent move involving both the Chinese legislature (the National People’s Congress) and the executive branch (the State Council), China has overhauled two of its most important pieces of legislation governing inbound...more
China’s Supreme People’s Court (SPC) recently circulated its Draft “Provisions on Several Issues concerning the Adjudication of Administrative Cases on Granting and Affirming Patent Rights (I)”...more
8/17/2018
/ Administrative Review ,
China ,
Claim Construction ,
Design Patent ,
Life Sciences ,
Patent Examinations ,
Patent Validity ,
Patents ,
Regulatory Oversight ,
Regulatory Standards ,
Supreme People's Court of China
16 April 2018 – Huawei’s jurisdictional challenge to Conversant Wireless’ patent infringement and FRAND determination proceedings has been dismissed by the High Court of England and Wales. ...more
6/28/2018
/ China ,
FRAND ,
Huawei ,
Injunctions ,
Intellectual Property Protection ,
IP License ,
Jurisdiction ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Qualcomm ,
Samsung ,
Standard Essential Patents ,
Telecommunications ,
Wireless Industry
On 12 May 2017, the Chinese Food and Drug Administration (the “CFDA”) issued several draft policies aimed at overhauling of the current regulations governing the Chinese pharma and medical device sector (the “Draft...more